Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H18N4O2S |
Molecular Weight | 450.512 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(OC2=C(\C=C(/C#N)C3=NC4=CC=CC=C4S3)C(=O)N5C=CC=C(C)C5=N2)=CC=C1
InChI
InChIKey=VFSVKVQMZDJFQX-NBVRZTHBSA-N
InChI=1S/C26H18N4O2S/c1-16-7-5-9-19(13-16)32-24-20(26(31)30-12-6-8-17(2)23(30)29-24)14-18(15-27)25-28-21-10-3-4-11-22(21)33-25/h3-14H,1-2H3/b18-14+
Molecular Formula | C26H18N4O2S |
Molecular Weight | 450.512 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/20571077Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/23054060 | https://www.ncbi.nlm.nih.gov/pubmed/26478461
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20571077
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/23054060 | https://www.ncbi.nlm.nih.gov/pubmed/26478461
CCG-63802 is a reversible inhibitor of regulator of G-protein signaling (RGS) protein, with the greatest potency at RGS4. Its mechanism seems to, at least in part, involve an allosteric action at the B site on the RGS which has been implicated in the physiological allosteric modulation of RGS proteins by acidic phospholipids and calmodulin. Regulators of G protein signaling (RGS) are major determinants of metabotropic receptor activity, reducing the lifespan of the GTP-bound state of G proteins. Inhibition of spinal RGS4 restored endogenous analgesic signaling pathways and mitigated neuropathic pain. Signalling through CB1 receptors may be involved in this beneficial effect.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1795091 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20571077 |
9.0 µM [IC50] | ||
Target ID: CHEMBL2034803 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20571077 |
112.0 µM [IC50] | ||
Target ID: P49795 Gene ID: 10287.0 Gene Symbol: RGS19 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20571077 |
20.0 µM [IC50] | ||
Target ID: O15492 Gene ID: 6004.0 Gene Symbol: RGS16 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/20571077 |
42.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26478461
Rats were treated with (0.05mg/mL, 10μL intrathecal injection)
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20571077
Biotinylated RGS proteins (5 nM, final assay concentration) were immobilized on Luminex LumAvidin beads and incubated with diluted compound in 50 mM HEPES, pH 8.0 at room temperature, 100 mM NaCl, 0.1% Lubrol, and 1 mM DTT, supplemented with 1% BSA. To each well of a 96-well PCR plate (Axygen, Union City, CA) Alexa Fluor 532-labeled G_o was added to a final concentration of 30 nM. This mixture was incubated for 30 min at room temperature in the dark, and then it was analyzed on a Luminex 200 flow cytometer for the bead-associated fluorescence (median value). Nonlinear regression analysis of inhibition curves was performed with Prism 5.0 (GraphPad Software Inc., San Diego CA)
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:51:31 GMT 2023
by
admin
on
Sat Dec 16 04:51:31 GMT 2023
|
Record UNII |
339BU4Y35U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID10211064
Created by
admin on Sat Dec 16 04:51:31 GMT 2023 , Edited by admin on Sat Dec 16 04:51:31 GMT 2023
|
PRIMARY | |||
|
6057678
Created by
admin on Sat Dec 16 04:51:31 GMT 2023 , Edited by admin on Sat Dec 16 04:51:31 GMT 2023
|
PRIMARY | |||
|
620112-78-9
Created by
admin on Sat Dec 16 04:51:31 GMT 2023 , Edited by admin on Sat Dec 16 04:51:31 GMT 2023
|
PRIMARY | |||
|
339BU4Y35U
Created by
admin on Sat Dec 16 04:51:31 GMT 2023 , Edited by admin on Sat Dec 16 04:51:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |